Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 744,027 |
|
|||||
| News | - | ||||||
| Day High | 7.63 | Low High |
|||||
| Day Low | 6.90 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prime Medicine Inc | PRME | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.45 | 6.36% | 7.53 | 16:02:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.19 | 6.90 | 7.63 | 7.53 | 7.08 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,656 | 744,027 | $ 7.30 | $ 5,429,266 | - | 4.11 - 17.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:08 | priorref | 172 | $ 7.53 | USD |
Prime Medicine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 903.14M | 119.94M | - | 0 | -198.13M | -1.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prime Medicine News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRME Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.88 | 7.63 | 5.88 | 6.73 | 848,798 | 1.65 | 28.06% |
| 1 Month | 4.69 | 7.63 | 4.11 | 5.50 | 866,690 | 2.84 | 60.55% |
| 3 Months | 8.28 | 9.77 | 4.11 | 6.27 | 712,117 | -0.75 | -9.06% |
| 6 Months | 6.65 | 9.86 | 4.11 | 7.04 | 669,459 | 0.88 | 13.23% |
| 1 Year | 13.96 | 17.20 | 4.11 | 8.79 | 559,350 | -6.43 | -46.06% |
| 3 Years | 18.97 | 21.7301 | 4.11 | 10.31 | 443,519 | -11.44 | -60.31% |
| 5 Years | 18.97 | 21.7301 | 4.11 | 10.31 | 443,519 | -11.44 | -60.31% |
Prime Medicine Description
| Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. |
